Shelter Harm Reduction Program Study
Part of Mental health clinical trials.
This study looks at a program called the Shelter Harm Reduction Program (HRSP) in New York City shelters. It aims to see if the program helps people who use drugs and stay in shelters. Researchers will interview people who have stayed in these shelters to learn about their experiences.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older.
- You speak English.
- You are staying or have stayed in a New York City single-adult shelter that has the HRSP (Shelter Harm Reduction Program) interventions.
- You have used drugs in the past year.
- You are able and willing to give your consent to participate.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how services like syringe exchange and overdose prevention centers might link people to mental health and addiction care. If you use opioids, stimulants, or inject drugs, this research may help improve care for others in similar situations.
This study tests a program to help prevent overdoses in supportive housing. It looks at how offering extra support and resources to tenants can reduce overdose risk and improve safety.
This study helps adults who recently left jail, prison, or similar facilities and have risks related to opioid use or HIV. It aims to connect them with treatment and care support starting from the emergency department.
This trial tests a peer-led program to help people with opioid use disorder build resilience and coping skills while they are in the hospital. The program is designed to support recovery and improve health outcomes.
This study tests a program that helps reduce harm from drinking for people in Housing First. It uses electronic tools and support to help you cut back safely.
This trial offers harm-reduction services for adults who have been misusing opioids (and sometimes other substances) recently. It’s designed to test support approaches that may reduce risks and improve well-being.
Hear when a new Overdose trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.